Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Nasulin v.Placebo on Blood Glucose Control in Patients With Type 2 DM Treated With Basal Insulin & Oral Antidiabetic Meds, Excluding Secretagogues in Phase 2A, Randomized, Parallel, Double-Blind, Placebo-Controlled, Multi-Center Study

NCT00850096 is registered in ClinicalTrials.gov with CPEX Pharmaceuticals Inc. as lead sponsor.

NCT NCT00850096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00850096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Nasulin v.Placebo on Blood Glucose Control in Patients With Type 2 DM Treated With Basal Insulin & Oral Antidiabetic Meds, Excluding Secretagogues in Phase 2A, Randomized, Parallel, Double-Blind, Placebo-Controlled, Multi-Center Study
Lead sponsor
CPEX Pharmaceuticals Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
March 31, 2010
Enrollment
94 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes